Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset Escherichia coli, Klebsiella Species, and Proteus mirabilis Bacteremia: MIC Matters

Background: Cefazolin is in vitro active against wild isolates of Escherichia coli, Klebsiella species, and Proteus mirabilis (EKP), but clinical evidence supporting the contemporary susceptibility breakpoint issued by the Clinical and Laboratory Standards Institute (CLSI) are limited. Methods: Betw...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Clin Med
Huvudupphovsmän: Hsieh, Chih-Chia, Chen, Po-Lin, Lee, Chung-Hsun, Yang, Chao-Yung, Lee, Ching-Chi, Ko, Wen-Chien
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI 2020
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7019784/
https://ncbi.nlm.nih.gov/pubmed/31936020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9010157
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk